Demo
Close Language Tab
Locate us
Languages
S
Sunrest Lifescience Ltd Pharmaceuticals
₹ 54.45 +3.35 (6.56%)
  • NSE
  • BSE

Overview

  • BSE Code 91669
  • NSE Symbol SUNREST
  • ISIN Demat INE0PLZ01012
  • Book Value (₹) 37.71
  • Face Value (₹) 10.00
  • Market Cap (₹ Cr.) 22.74
  • P/E (TTM) 11.37
  • EPS (TTM) 4.66
  • Div Yield (%) 0.00

Performance

Today’s Low 54.45
Today’s High 54.45

54.45
52W Low 44.60
52W High 75.00

54.45
Open 54.45
Prev. Close 51.10
Volume 1,00,800.00

Corporate Actions

Sunrest Lifescience Limited - Certificate under SEBI (Depositories and Participants) Regulations, 2018
Apr 15, 2025

Sunrest Lifescience Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

About Sunrest Lifescience Ltd

Sunrest Lifescience Limited was initially formed as 'Sunrest Lifescience Private Limited' as a Private Limited Company vide Certificate of Incorporation dated October 30, 2017, as registered with the Registrar of Companies, Ahmedabad, Gujarat. Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to 'Sunrest Lifescience Limited'. A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company was as registered with the Registrar of Companies, Ahmedabad on March 21, 2023.

the Company is engaged in marketing of OTC generic pharmaceutical products into domestic market. the Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.

the Company gets product manufactured from one of their Group Company, Trilend Pharmaceuticals Private Limited. Apart from this, Company has acquired 11,000 equity shares of Trilend, constituting 9.90% of its paid-up share capital.

the Company came up with its Initial Public Offering of 12,91,200 Equity Shares of Rs 10/- each by raising funds aggregating to Rs 10.84 Crore through Fresh Offer in November, 2023.

Founded: 2017
Chairman: Juhi Sawajani
Managing Director: Nikhilkumar Y Thakkar
Address: FF-41 Ajaj Tenament 6 Near Can, -al Nr Ritanagar Sta Vastal Rd, Ahmedabad, Gujarat, 382415,